Melola Discovery

← Melola Discovery

Jurnal SINTA 1

DETECTION OF CYTOKERATIN 19 MRNA IN BLOOD AS AN EARLY MARKER OF MICROMETASTATIC TUMOR CELLS OF NASOPHARYNGEAL CARCINOMA PATIENTS IN SURABAYA

Folia Medica Indonesiana · Vol. 44 No. 2 (2008)

ISSN
2355-8393, 2599-056X
Terbit
2008-04-01
Penerbit
Airlangga University
Bahasa
en

Abstrak

Nasopharyngeal carcinoma (NPC) is a unique epithelial malignancy triggered by Epstein Barr virus that occurs at a high frequency in certain regions of southeast Asia. Previous studies reported that this tumor was a radiosensitive but the predominant failure after adequate radiotherapy was due to its distant metastasis. It would be of value to detect the presence of metastasis as early as possible. Previous studies have shown that cytokeratin 19 (Ck 19) positive cells indicate the presence of micrometastasis. The purpose of this study was to evaluate the presence of Ck 19 mRNA by nested RT-PCR in established NPC patients and its correlation to the various stages of NPC as determined by conventional clinical examination. The reported sensitivity of RT-PCR was around 1/107, i.e one cancer cell can be detected among 107 normal blood cells. Venous blood samples from 30 patients with biopsy-proven nasopharyngeal carcinoma and 10 ENT non NPC patients were tested. After we isolated total mRNA with Trizol reagent, the procedure was continued with nested RT-PCR. The primer sets were directed to conserved regions of Ck 19 genome encoding cytokeratin protein (outer primers Ck 19-1 & Ck 19-2 and inner primers Ck 19-3 & Ck 19-4). A distinct 518 bp band (it cannot be seen on agarose gel electrophoresis) and 371 bp of the PCR products indicated the presence of mRNA Ck 19. Results showed that Ck 19 mRNA was obtained in 22 (73%) of 25 NPC patients with several stages and none of 10 (0%) ENT non NPC patients. We divided 30 NPC patients into 4 groups according to TNM system (WHO criteria) Stage I none, Stage IIa 1 patient (Ck 19 mRNA was negative), Stage IIb 1 patient (Ck 19 mRNA was negative), Stage III 3 patients from 5 patients had Ck 19 mRNA positive (60%), Stage IVa 5 patients from 7 had Ck 19 mRNA positive (72%) and Stage IVb 14 patients from 16 patients had Ck 19 mRNA positive (87,5%). No Ck 19 positive cells were detected in control group, 10 patients ENT non NPC (0%), i.e 100% specificity. Our data indicated that the positive detection rate for Ck 19 mRNA in peripheral blood increased as the clinical stage of tumor increased, and the correlation was strong with statistical significance of r = 0.95 and t > 0.02. In conclusion, this study shows that the presence of Ck 19 mRNA, as detected by RT-PCR in NPC, is only significantly associated with micrometastasis tumor. It is a highly specific and sensitive method. Ck 19 mRNA detection is a useful and reliable method to monitor local recurrence and tumor metastasis in NPC patients. It helps to detect recurrence and tumor metastasis early and may improve local and systemic control and enhance patient’s survival.

Kata kunci

Jaringan kolaborasi para penulis

33 penulis · 251 tautan kepenulisan bersama · 106 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Universitas Airlangga
  • Universitas Muhammadiyah Jember
  • Universitas Gadjah Mada
  • Universiti Teknologi MARA
  • Rumah Sakit Dokter Soetomo
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Ema QurnianingsihUniversitas Airlangga4
Indri SafitriUniversitas Airlangga4
Soetjipto SoetjiptoUniversitas Airlangga3
Citrawati Dyah Kencono WunguUniversitas Airlangga3
Lina LukitasariUniversitas Airlangga3
Ira HumairahUniversitas Airlangga3
Siti KhaerunnisaUniversitas Airlangga3
Gwenny Ichsan PrabowoUniversitas Airlangga3
Arief BakhtiarUniversitas Airlangga2
Susi Wahyuning AsihUniversitas Muhammadiyah Jember2
Irmi Syafa’ahRumah Sakit Dokter Soetomo2
Suwandito SuwanditoUniversitas Airlangga2
Zuhrotul Eka Yulis AnggraeniUniversitas Muhammadiyah Jember2
Ginanjar Sasmito AdiUniversitas Muhammadiyah Jember2
Ely Rahmatika NugrahaniUniversitas Muhammadiyah Jember2
Ayesie Natasa ZulkaUniversitas Muhammadiyah Jember2
Chiquita PrahasantiAfiliasi tidak diketahui1
Eunike LayUniversitas Airlangga1
Bayu Satria WiratamaUniversitas Gadjah Mada1
Hendri SusiloUniversitas Airlangga1
Clarissa ElvarettaUniversitas Airlangga1
Dian Eka Roro PalupiUniversitas Airlangga1
Fithriyah Cholifatul UmmahUniversitas Airlangga1
Langgeng Agung WaskitoUniversitas Airlangga1
Indah Mohd AminUniversiti Teknologi MARA1
Dita Sukmaya PrawitasariUniversitas Airlangga1
Jemima Lewi SantosoUniversitas Airlangga1
OE PalandengAfiliasi tidak diketahui1
HoetomoAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">DETECTION OF CYTOKERATIN 19 MRNA IN BLOOD AS AN EARLY MARKER OF MICROMETASTATIC TUMOR CELLS OF NASOPHARYNGEAL CARCINOMA PATIENTS IN SURABAYA</dc:title><dc:creator>Harianto Notopuro</dc:creator><dc:creator>Widodo Ario Kentjono</dc:creator><dc:creator>Retno Handajani</dc:creator><dc:creator>Francisca Notopuro</dc:creator><dc:subject>nasopharyngeal carcinoma</dc:subject><dc:subject>cytokeratin 19</dc:subject><dc:subject>CK19 mRNA</dc:subject><dc:subject>circulating tumor cells</dc:subject><dc:subject>micrometastases</dc:subject><dc:subject>early cancer detection</dc:subject><dc:subject>serum biomarkers</dc:subject><dc:subject>TNM staging</dc:subject><dc:subject>Epstein-Barr virus</dc:subject><dc:subject>radiotherapy failure</dc:subject><dc:subject>distant metastasis</dc:subject><dc:description xml:lang="en">Nasopharyngeal carcinoma (NPC) is a unique epithelial malignancy triggered by Epstein Barr virus that occurs at a high frequency in certain regions of southeast Asia. Previous studies reported that this tumor was a radiosensitive but the predominant failure after adequate radiotherapy was due to its distant metastasis. It would be of value to detect the presence of metastasis as early as possible. Previous studies have shown that cytokeratin 19 (Ck 19) positive cells indicate the presence of micrometastasis. The purpose of this study was to evaluate the presence of Ck 19 mRNA by nested RT-PCR in established NPC patients and its correlation to the various stages of NPC as determined by conventional clinical examination. The reported sensitivity of RT-PCR was around 1/107, i.e one cancer cell can be detected among 107 normal blood cells. Venous blood samples from 30 patients with biopsy-proven nasopharyngeal carcinoma and 10 ENT non NPC patients were tested. After we isolated total mRNA with Trizol reagent, the procedure was continued with nested RT-PCR. The primer sets were directed to conserved regions of Ck 19 genome encoding cytokeratin protein (outer primers Ck 19-1 &amp; Ck 19-2 and inner primers Ck 19-3 &amp; Ck 19-4). A distinct 518 bp band (it cannot be seen on agarose gel electrophoresis) and 371 bp of the PCR products indicated the presence of mRNA Ck 19. Results showed that Ck 19 mRNA was obtained in 22 (73%) of 25 NPC patients with several stages and none of 10 (0%) ENT non NPC patients. We divided 30 NPC patients into 4 groups according to TNM system (WHO criteria) Stage I none, Stage IIa 1 patient (Ck 19 mRNA was negative), Stage IIb 1 patient (Ck 19 mRNA was negative), Stage III 3 patients from 5 patients had Ck 19 mRNA positive (60%), Stage IVa 5 patients from 7 had Ck 19 mRNA positive (72%) and Stage IVb 14 patients from 16 patients had Ck 19 mRNA positive (87,5%). No Ck 19 positive cells were detected in control group, 10 patients ENT non NPC (0%), i.e 100% specificity.  Our data indicated that the positive detection rate for Ck 19 mRNA in peripheral blood increased as the clinical stage of tumor increased, and the correlation was strong with statistical significance of r = 0.95 and t &gt; 0.02. In conclusion, this study shows that the presence of Ck 19 mRNA, as detected by RT-PCR in NPC, is only significantly associated with micrometastasis tumor. It is a highly specific and sensitive method. Ck 19 mRNA detection is a useful and reliable method to monitor local recurrence and tumor metastasis in NPC patients. It helps to detect recurrence and tumor metastasis early and may improve local and systemic control and enhance patient’s survival.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2008-04-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>http://journal.unair.ac.id/filerPDF/03%20Harianto.pdf</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 44 No 2 (2008)</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language></oai_dc:dc>